Auricular Stimulation Reduces Cardiac Postoperative AF Risk
|
By HospiMedica International staff writers Posted on 06 Nov 2019 |

Image: Graphical abstract of the study (Photo courtesy of Martin Andreas / MedUniWien).
A new study reveals that postoperative atrial fibrillation (POAF) complications could be halved by non-invasive electrical stimulation of the vagus nerve directly on the ear.
Researchers at the Medical University of Vienna (MedUniWien; Austria) conducted a randomized 1:1 study to examine the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in 40 patients slated for cardiac surgery. Following surgery, electrical stimulation electrodes were applied in the triangular fossa of the ear for up to two weeks. Heart rhythm was recorded continuously via Holter electrocardiogram (ECG), and C-reactive protein (CRP) and interleukin-6 plasma concentrations were measured.
The results revealed that the patients receiving LLTS (amplitude one mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) had a significantly reduced occurrence of POAF (4 of 20 events) when compared with the control group (11 of 20 events) during a similar mean Holter ECG recording period. The median duration of POAF was comparable between the treatment and the control group, and no effect of the LLTS application on CRP or IL-6 levels was detectable. The study was published on October 10, 2019, in Circulation: Arrhythmia and Electrophysiology.
“Electrical stimulation of the ear and the vagus nerve that sits on the surface there has a calming effect, in that we are stimulating the largest nerve of the parasympathetic nervous system and hence the corresponding antagonists,” said lead author Martin Andreas, MD, PhD, of the department of surgery. “This stimulation is given continuously in the first five days after an operation, when the risk of POAF is at its highest, and is then stopped, if everything goes well. The innovative product, from an Austrian company from Mauerbach, has already been successfully used for vascular occlusions.”
POAF occurs in up to 40% of patients undergoing cardiac surgery. Conventional viewpoints suggest that it is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is also associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.
Related Links:
Medical University of Vienna
Researchers at the Medical University of Vienna (MedUniWien; Austria) conducted a randomized 1:1 study to examine the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in 40 patients slated for cardiac surgery. Following surgery, electrical stimulation electrodes were applied in the triangular fossa of the ear for up to two weeks. Heart rhythm was recorded continuously via Holter electrocardiogram (ECG), and C-reactive protein (CRP) and interleukin-6 plasma concentrations were measured.
The results revealed that the patients receiving LLTS (amplitude one mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) had a significantly reduced occurrence of POAF (4 of 20 events) when compared with the control group (11 of 20 events) during a similar mean Holter ECG recording period. The median duration of POAF was comparable between the treatment and the control group, and no effect of the LLTS application on CRP or IL-6 levels was detectable. The study was published on October 10, 2019, in Circulation: Arrhythmia and Electrophysiology.
“Electrical stimulation of the ear and the vagus nerve that sits on the surface there has a calming effect, in that we are stimulating the largest nerve of the parasympathetic nervous system and hence the corresponding antagonists,” said lead author Martin Andreas, MD, PhD, of the department of surgery. “This stimulation is given continuously in the first five days after an operation, when the risk of POAF is at its highest, and is then stopped, if everything goes well. The innovative product, from an Austrian company from Mauerbach, has already been successfully used for vascular occlusions.”
POAF occurs in up to 40% of patients undergoing cardiac surgery. Conventional viewpoints suggest that it is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is also associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.
Related Links:
Medical University of Vienna
Latest Critical Care News
- Wearable Sweat Test Simplifies Cystic Fibrosis Diagnosis
- New Risk Calculator Identifies Heart Disease Earlier in Postpartum Women
- New Soft Optical Sensor Advances Heart and Brain Activity Mapping
- AI System Stabilizes Oxygen Levels More Reliably Than Standard Care
- Radiation-Free Cardiac Catheterization Improves Care for Children
- Simple Triage Protocol Reduces Emergency Department Length of Stay
- ECG-Based AI Detects Left Ventricular Dysfunction and Heart Failure
- Stretchable Hydrogel Electrodes Maintain Stable Signals During Movement
- New AI Wearable System Supports 24-Hour Sleep and Metabolic Regulation
- Sweat-Sensing Fingertip Patch Continuously Tracks Parkinson’s Medication Levels
- Postoperative Treatment Windows Enable Targeted Glioblastoma Therapy
- New Medical Masks and Gowns Support Protection Across Care Settings
- FDA Clears Software for Objective Assessment of Cognitive Function
- Stretchable Antenna Enables Reliable Wearable ECG Monitoring During Motion
- FDA Clears Noninvasive Test for Elevated Pulmonary Capillary Wedge Pressure
- FDA-Cleared Index Enables Pediatric-Specific Sedation Monitoring
Channels
Artificial Intelligence
view channelCollaborative AI System Improves Medical Diagnostic Accuracy
Hospitals face a persistent trade-off when deploying artificial intelligence for diagnosis. Broad “generalist” models handle many tasks but often lack disease-specific precision. Narrow “specialist” models... Read more
AI-Powered Brain-Body Interface Supports Movement and Sensation Recovery
Neurological injuries such as stroke and spinal cord trauma frequently leave patients with profound motor and sensory deficits that limit independence. Rehabilitation may restore some movement, but recovery... Read moreSurgical Techniques
view channel
New Implant Provides Sustained Localized Therapy for Ovarian Cancer
Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Combined Phage and Microbiota Therapy May Reduce Recurrent Urinary Tract Infections
Recurrent urinary tract infections (rUTIs) are frequent relapses of urinary infections that persist despite standard therapy. They increase morbidity, expose patients to repeated antibiotic courses, and... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreMedical Imaging
view channel
MRI-Guided Ultrasound Method Advances Targeted Treatment of Gliomas
Gliomas, the most common primary brain tumors in adults, include glioblastoma, the deadliest form of brain cancer. Drug delivery is hampered by the brain’s blood-brain barrier, limiting treatment efficacy... Read more
AI Accelerates Individualized Dosimetry for Prostate Cancer Treatment
Radiopharmaceutical therapy is an injected cancer treatment that delivers radiation through the body while selectively targeting tumors. In prostate cancer, current dosing remains largely uniform despite... Read moreHealth IT
view channel
Short Digital Training Program Improves Motor Function in Parkinson’s Disease
Parkinson's disease causes motor symptoms that interfere with movement and daily activities. Drug treatment is standard care, yet additional approaches are needed to target motor control.... Read moreNew Cloud Platform Streamlines Capsule Endoscopy Workflow and Reporting
Capsule endoscopy programs depend on coordinated acquisition, review, and reporting to support gastrointestinal services. Managing these activities across practices and health systems requires reliable... Read morePoint of Care
view channelRapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
Respiratory infections in long-term care residents frequently trigger emergency department transfers that strain hospital capacity and expose frail patients to additional risks. Turnaround delays from... Read more
New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
Transporting postoperative patients for CT or MRI can create operational burdens, delays, and disruptions in care. Bedside visualization may help reduce transport demands, lower radiation exposure, and... Read moreBusiness
view channel
AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
Lung cancer remains the leading cause of cancer mortality, and screening programs rely on computed tomography to identify disease earlier when curative treatment is more likely. High patient volumes and... Read more







